Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations

被引:58
|
作者
Boettcher, Sebastian [1 ]
Ritgen, Matthias [1 ]
Buske, Sebastian [1 ]
Gesk, Stefan [2 ]
Klapper, Wolfram [3 ,4 ]
Hoster, Eva [5 ]
Hiddemann, Wolfgang [5 ]
Unterhalt, Michael [5 ]
Dreyling, Martin [5 ]
Siebert, Reiner [2 ]
Kneba, Michael [1 ]
Pott, Christiane [1 ]
机构
[1] Univ Schleswig Holstein, Dept Med 2, Kiel, Germany
[2] Univ Schleswig Holstein, Inst Human Genet, Kiel, Germany
[3] Univ Schleswig Holstein, Dept Haematopathol, Kiel, Germany
[4] Univ Schleswig Holstein, Lymph Node Registry Kiel, Kiel, Germany
[5] Univ Munich, Hosp Grosshadern, Dept Internal Med 3, Munich, Germany
关键词
mantle cell lymphoma; flow cytometry; PCR; staging; minimal residual disease;
D O I
10.3324/haematol.11267
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The increasing application of multi-color flow cytometry assays for staging and follow-up in mantle cell lymphoma necessitates that the specificity and sensitivity of this technique are evaluated. Data from prospective clinical trials comparing the clinical applicability of flow cytometry to routine diagnostic methods and to polymerase chain reaction are currently lacking. Design and Methods We applied a standardized four-color flow cytometry assay to 281 prospectively collected peripheral blood and bone marrow samples from 98 patients with mantle cell lymphoma participating in a multi-center clinical trial and compared the results to those obtained with conventional clinical staging and consensus primer IGH-polymerase chain reaction. Results The maximum sensitivity of flow cytometry using light chain restriction in CD19'CD5' sub-populations was 8.0x10(-4) while flow cytometry that relied on immunophenotypic aberrations was less sensitive (2.4x10(-3)). Mantle cell lymphoma cells were detected in 87.3% of 110 pre-treatment samples from 84 patients by flow cytometry and in 94.5% by polymerase chain reaction. Eight out of 84 patients (9.5%) diagnosed clinically as having stage II or III disease showed peripheral blood or bone marrow involvement according to flow cytometry, thus documenting more advanced disease. At follow-up residual lymphoma cells were detected by flow cytometry and concordantly by polymerase chain reaction in 10/171 samples (5.8%); however, 31 follow-up samples (18.1%) were positive for minimal residual disease according only to polymerase chain reaction analysis. Conclusions The sensitivity of four-color flow cytometry is comparable to that of IGH-polymerase chain reaction at initial staging but is less sensitive at follow-up after immuno-chemotherapy. Both techniques are highly valuable methods for accurate initial staging.
引用
收藏
页码:551 / 559
页数:9
相关论文
共 14 条
  • [1] Clinical value of flow cytometric immunophenotyping analyses for minimal residual disease detection in stem-cell products in patients with follicular and mantle cell lymphoma: comparison to IgH-polymerase chain reaction
    Kato, H.
    Yamamoto, K.
    Oki, Y.
    Chihara, D.
    Ine, S.
    Taji, H.
    Seto, M.
    Kagami, Y.
    Morishima, Y.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S198 - S198
  • [2] Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation
    Böttcher, S
    Ritgen, M
    Pott, C
    Brüggemann, M
    Raff, T
    Stilgenbauer, S
    Döhner, H
    Dreger, P
    Kneba, M
    LEUKEMIA, 2004, 18 (10) : 1637 - 1645
  • [3] Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation
    S Böttcher
    M Ritgen
    C Pott
    M Brüggemann
    T Raff
    S Stilgenbauer
    H Döhner
    P Dreger
    M Kneba
    Leukemia, 2004, 18 : 1637 - 1645
  • [4] Four-color flow cytometry bypasses limitations of IG/TCR polymerase chain reaction for minimal residual disease detection in certain subsets of children with acute lymphoblastic leukemia
    Robillard, Nelly
    Cave, Helene
    Mechinaud, Francoise
    Guidal, Christine
    Garnache-Ottou, Francine
    Rohrlich, Pierre Simon
    Avet-Loiseau, Herve
    Garand, Richard
    HAEMATOLOGICA, 2005, 90 (11) : 1516 - 1523
  • [5] Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease
    Andersen, NS
    Donovan, JW
    Borus, JS
    Poor, CM
    Neuberg, D
    Aster, JC
    Nadler, LM
    Freedman, AS
    Gribben, JG
    BLOOD, 1997, 90 (10) : 4212 - 4221
  • [6] Detection of Minimal Residual Disease in Mantle Cell Lymphoma-Establishment of Novel Eight-Color Flow Cytometry Approach
    Chovancova, Jana
    Bernard, Tomas
    Stehlikova, Olga
    Salek, David
    Janikova, Andrea
    Mayer, Jiri
    Doubek, Michael
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2015, 88 (02) : 92 - 100
  • [7] MRD detection in mantle cell lymphoma: Flow cytometry is comparable to consensus primer IgH-PCR at initial staging, but less sensitive than PCR after combined immuno-chemotherapy.
    Boettcher, S
    Ritgen, M
    Siebert, R
    Buske, S
    Klingenberg, M
    Unterhalt, M
    Hiddemann, W
    Dreyling, MH
    Kneba, M
    Pott, C
    BLOOD, 2005, 106 (11) : 546A - 546A
  • [8] Reverse transcriptase/polymerase chain reaction follow-up and minimal residual disease detection in t(1;19)-positive acute lymphoblastic leukaemia
    Privitera, E
    Rivolta, A
    Ronchetti, D
    Mosna, G
    Giudici, G
    Biondi, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (03) : 653 - 658
  • [9] Minimal residual disease detection in hairy cell leukemia - Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene
    Sausville, JE
    Salloum, RG
    Sorbara, L
    Kingma, DW
    Raffeld, M
    Kreitman, RJ
    Imus, PD
    Venzon, D
    Stetler-Stevenson, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (02) : 213 - 217
  • [10] Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia
    Gameiro, P
    Moreira, I
    Yetgin, S
    Papaioannou, M
    Potter, MN
    Prentice, HG
    Hoffbrand, AV
    Foroni, L
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) : 685 - 696